Tristel (LON:TSTL) Hits New 1-Year Low – What’s Next?

Tristel plc (LON:TSTL) shares reached a new 52-week low during mid-day trading on Wednesday . The stock traded as low as GBX 346 ($4.52) and last traded at GBX 362 ($4.73), with a volume of 209155 shares traded. The stock had previously closed at GBX 357.50 ($4.67).

Tristel Stock Up 1.3 %

The company has a debt-to-equity ratio of 19.12, a current ratio of 4.92 and a quick ratio of 3.83. The firm has a 50-day moving average of GBX 432.35 and a 200 day moving average of GBX 446.82. The stock has a market capitalization of £172.49 million, a price-to-earnings ratio of 2,750.00 and a beta of 0.23.

Insider Activity

In other Tristel news, insider Elizabeth Dixon sold 50,000 shares of the company’s stock in a transaction on Thursday, September 19th. The shares were sold at an average price of GBX 397 ($5.18), for a total transaction of £198,500 ($259,206.06). 4.89% of the stock is currently owned by insiders.

Tristel Company Profile

Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom and internationally. The company operates through three segments: Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other. It offers medical instrument disinfection products, including airway management, cardiology, ear, nose and throat, endoscopy, gastrointestinal physiology, laboratory, ophthalmology, phlebotomy, reproductive health/IVF, surface, ultrasound, urology, women's health, and other products under the Tristel brand.